Cargando…
Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study
Background: Psychotic disorders are associated with high rates of comorbid substance use disorders. Use of cannabis rich in tetrahydrocannabinol (THC) is linked to an increased risk of psychosis, worsening of psychotic symptoms, and an adverse course of psychotic disorders. Previous studies suggest...
Autores principales: | Köck, Patrick, Lang, Elisabeth, Trulley, Valerie-Noelle, Dechent, Frieder, Mercer-Chalmers-Bender, Katja, Frei, Priska, Huber, Christian, Borgwardt, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599279/ https://www.ncbi.nlm.nih.gov/pubmed/34803760 http://dx.doi.org/10.3389/fpsyt.2021.736822 |
Ejemplares similares
-
The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders
por: Eickhoff, Sofia, et al.
Publicado: (2022) -
Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder
por: Meyer, Maximilian, et al.
Publicado: (2021) -
Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability – a randomized clinical trial
por: Egloff, Laura, et al.
Publicado: (2023) -
Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis
por: Monti, Manuela Carla, et al.
Publicado: (2022) -
Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)
por: Dieterle, Markus, et al.
Publicado: (2022)